BofA lowered the firm’s price target on Molina Healthcare (MOH) to $155 from $166 and keeps an Underperform rating on the shares. Molina lowered EPS guidance for the third time this year and expects 2026 EPS to be flat at $14, which is 40% below consensus of $19.33, the analyst noted. Following the guidance cuts, the firm lowered its own estimates and takes a more cautious approach given risk pool uncertainty in Medicaid/exchanges.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MOH:
- Molina Healthcare Stock (MOH) Plunges on Dismal Q3 Earnings, Guidance Cut
- Closing Bell Movers: Tesla and IBM fall as Q3 results disappoint
- Molina Healthcare sees Fy25 revenue $44.5B, consensus $44.56B
- Molina Healthcare sees FY26 EPS ‘approximating’ FY25
- Molina Healthcare down 17% at $161.00 after Q3 earnings miss, guidance cut